Home » Posts tagged with » Novel Coronavirus
Coronavirus vaccine trial results : Moderna mRNA-1273 shows early promise

Coronavirus vaccine trial results : Moderna mRNA-1273 shows early promise

Moderna said that mRNA-1273, its novel coronavirus vaccine candidate, has delivered positive interim data in a phase 1 clinical trial by eliciting neutralizing antibody titer levels in all eight initial participants across the 25 µg and 100 µg dose cohorts. The early-stage clinical trial in humans was led by the US National Institute of Allergy […]

Verndari begins preclinical testing of COVID-19 vaccine candidate

Verndari, a California-based biopharma company, has started preclinical testing of a COVID-19 vaccine candidate, which will be administered using it microneedle array dermal patch VaxiPatch. The preclinical testing will be carried out in laboratories at the University of California in Davis (UC Davis). Verndari, which was established in 2015, is said to have developed the […]

Continue reading …
COVID-19 RT-PCR detection kit : Fosun Pharma secures FDA EUA status

Shanghai Fosun Pharmaceutical (Fosun Pharma) has been granted the emergency use authorization (EUA) status for its COVID-19 RT-PCR detection kit from the US Food and Drug Administration (FDA). Fosun Long March, a fully-owned subsidiary of Fosun Pharma, developed the COVID-19 RT-PCR detection kit which already has a medical device registration certificate from the China National Medical […]

Continue reading …
Oxford University ChAdOx1 nCoV-19 vaccine trial begins in humans

Researchers at the University of Oxford in the UK have commenced the ChAdOx1 nCoV-19 vaccine trial in healthy human volunteers to test the vaccine candidate’s ability in protecting against the novel coronavirus. Nearly 1,100 people, aged between 18 and 55 are taking part in the Oxford University coronavirus vaccine trial, of which half of them […]

Continue reading …
DNA-based COVID-19 vaccine candidate being developed by University of Waterloo

DNA-based COVID-19 vaccine candidate : Researchers at the University of Waterloo in Canada are developing a DNA-based vaccine candidate which can be given via nasal route to protect from novel coronavirus. The vaccine will be formulated to work on tissues in the nasal cavity and lower respiratory tract which will enable it to replicate within […]

Continue reading …
Sinovac Biotech gets approval to begin coronavirus vaccine trial

Coronavirus vaccine trial : Chinese biopharma company Sinovac Biotech has secured approval to carry out a human clinical trial on an inactivated COVID-19 vaccine candidate, which it had been developing since late January. The company said that its scientists have quickly wrapped up comprehensive preclinical studies in collaboration with some of the top academic research […]

Continue reading …
DiaSorin set to launch LIAISON SARS-CoV-2 IgG kit for testing COVID-19

LIAISON SARS-CoV-2 IgG kit : DiaSorin said that it has completed studies at the Policlinico San Matteo in Pavia, Italy to support the roll out of a new serological and high-processing volume test to detect the presence of antibodies in people infected with the SARS-CoV-2 virus associated with COVID-19. The Italian diagnostic company is working […]

Continue reading …
Incyte to launch ruxolitinib coronavirus clinical trial in US

Ruxolitinib coronavirus clinical trial : Incyte revealed that it is working with the US Food and Drug Administration (FDA) to launch the phase 3 RUXCOVID clinical trial to assess the efficacy and safety of ruxolitinib (Jakafi) plus standard-of-care (SoC) in patients with COVID-19 associated cytokine storm syndrome. The ruxolitinib plus standard-of-care will be compared to […]

Continue reading …
Promega master mix approved for use in CDC’s COVID-19 diagnostic panel

Promega Corporation said that its GoTaq Probe 1-Step RT-qPCR System is now available in Centers for Disease Control and Prevention COVID-19 diagnostic protocol for emergency use. Available through the CDC’s Emergency Use Authorization (EUA), the Promega tool is an approved master mix option for the 2019-Novel Coronavirus Real-Time RT-PCR Diagnostic Panel of the CDC. Recently, […]

Continue reading …
Johnson & Johnson coronavirus vaccine targeted to be launched in early 2021

Johnson & Johnson said that it has selected a lead coronavirus vaccine candidate from constructs it has been working on since the start of this year, which it aims to bring it to the market in early 2021 through emergency use authorization. The company, in this connection, said that its subsidiary Janssen Pharmaceutical has significantly […]

Continue reading …
Page 1 of 3123